Video

Complementary Therapy and Exercise in Patients With MPNs

Ruben Mesa, M.D., director of the UT Health San Antonio Cancer Center, discusses complementary therapy for patients with myeloproliferative neoplasms (MPNs).

Ruben Mesa, M.D., director of the UT Health San Antonio Cancer Center, discusses complementary therapy for patients with myeloproliferative neoplasms (MPNs).

Even on standard MPN therapy, such as JAK inhibitors, many patients will still have residual issues, such as fatigue and itching, so complementary therapies may be of help. Currently, Mesa’s team is investigating the effectiveness of such therapies. Meanwhile, physical activity has been known to improve quality of life in patients undergoing cancer treatment. However, it is important that patients don’t overdo it and get the approval of their health care team before starting a new workout regimen.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Related Content